1. Fenofibrate: influence on circulating lipids and side-effects in medium and long-term clinical use;Blane,1986
2. Mechanism of action of fenoflbrate: new data;Pascal,1987
3. Fenofibrate treatment inhibits HMG-CoA reductase activity in mononuclear cells from hyperlipoproteinemic patients;Schneider;Atherosclerosis,1985
4. Increase in lipoprotein lipase activity after procetofen (fenofibrate) treatment in primary hyperlipoproteinemia;Rubba;Clin Ter Cardiovasc,1982
5. Etude pharmacologique de trois médicaments normolipémiants utilisant le test d'hyperiipémie au Triton WR-1339;Fruchart,1982